Evaluation of the implementation of a rapid response treatment protocol for patients with acute onset stroke: can we increase the number of patients treated and shorten the time needed?

Cerebrovasc Dis Extra · 2014 · PMC4093647 · PMID 25076956

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

This practice involves a certain, quite significant risk that patients with thrombocytopenia or an elevated international normalized ratio could be treated with recombinant tissue plasminogen activator.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.